Ulrich Maurer

Ulrich Maurer Profile Page

Contact

Lab:	Dr. Ulrich Maurer
Department:	Institute for Molecular Medicine and Cell Research
Phone:	203 9632/9613
E-mail:	This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Lab homepage:	www.mol-med.uni-freiburg.de/mom-en/mau
PhD positions available:	YES
Research Area:	Molecular Medicine
Research Interests:	Signaling of cell death and survival

CV

Education & Training:	1988-1994: Study of Biotechnology, Dipl.-Ing. (FH), Applied University of Rheinland Pfalz, Germany 1996-1999: Study of Biology, University of Frankfurt 1999: Dr. phil.nat., Biochemistry, University of Frankfurt
Employment & Experience:	1999-2000: Postdoctoral Fellow in Hematology/Oncology, University of Ulm, Germany 2000-2005: Postdoctoral Fellow in Cellular Immunology, La Jolla Institute for Allergy and Immunology, San Diego, USA 2006-present: Group leader Institute for Molecular Medicine and Cell Research, University of Freiburg, Germany

Honors

Honors and Awards:

2000-2002: Research Fellowship, Mildred Scheel Stiftung /Deutsche Krebshilfe

Publications

Selected Publications:

Brauns-Schubert P, Schubert F, Wissler M, Weiss M, Schlicher L, Bessler B, Safavi M, Miething C, Borner C, Brummer T and Maurer U (2017): CDK9-mediated phosphorylation controls the interaction of TIP60 with the transcriptional machinery. EMBO Rep, accepted for publication

Schlicher L, Wissler M, Preiss F, Brauns-Schubert P, Jakob C, Dumit V, Borner C, Dengjel J, and Maurer U (2016): SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death. EMBO Rep, 17, 1485-7 Article

Lindner SE, Wissler M, Gründer A, Aumann K, Ottina E, Peintner L, Borner C, Charvet C, Villunger A, Pahl HL, Maurer U (2014): Increased leukocyte survival and accelerated onset of lymphoma in absence of MCL-1 S159-phosphorylation. Oncogene, 33, 5521-4. Abstract

Charvet C, Wissler M, Brauns-Schubert P, Wang SJ, Tang Y, Sigloch FC, Mellert H, Brandenburg M, Lindner SE, Breit B, Green DR, McMahon SB, Borner C, Gu W, Maurer U (2011): Phosphorylation of Tip60 by GSK-3 Determines the Induction of PUMA and Apoptosis by p53. Mol Cell 42, 584-96 Abstract

Colell A, Ricci JE, Tait S, Milasta S, Maurer U, Bouchier-Hayes L, Fitzgerald P, Guio-Carrion A, Waterhouse NJ, Wei Li C, Newmeyer DD, Beere HM, Green DR (2007): Glyceraldehyde-3-phosphate dehydrogenase and autophagy protect cells from apoptotic cytochrome c release in the absence of caspase activation. Cell, Jun 1;129(5):983-97 Abstract

Maurer U, Charvet C, Wagman A, Dejardin EM, Green DR (2006): Glycogen Synthase Kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell 21, 749-60 Abstract

Viatour P, Dejardin E, Warnier M, Lair F, Claudio E, Bureau F, Marine JC, Merville MP, Maurer U, Green D, Piette J, Siebenlist U, Bours V, Chariot A (2004): GSK3-mediated BCL-3 phosphorylation modulates its degradtion and its oncogenicity. Mol Cell 16, 35-45 Abstract

Chipuk JE, Maurer U, Green D R, Schuler M (2003): Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription. Cancer Cell 4, 371-381 Abstract

Hubinger, G, Wehnes, E, Xue L, Morris SW, Maurer U (2003): Hammerhead ribozyme-mediated cleavage of the fusion transcript NPM-ALK associated with anaplastic large-cell lymphoma. Exp Hematol 31, 226-233 Abstract

Hubinger G, Schmid M, Linortner S, Manegold A, Bergmann L, Maurer U (2001): Ribozyme-mediated cleavage of wt1 transcripts suppresses growth of leukemia cells. Exp Hematol 29, 1226-1235 Abstract

SGBM PhD students

SGBM PhD students:

Laura Griewahn (since July 2018)

ALUMNI

Florian Schubert (graduated April 2018)

Priska Brauns-Schubert (graduated June 2017)

Lisa Schlicher (graduated May 2017)